Literature DB >> 11554757

Mutation of N304 to leucine in Streptomyces clavuligerus deacetoxycephalosporin C synthase creates an enzyme with increased penicillin analogue conversion.

H S Chin1, J Sim, T S Sim.   

Abstract

Superimposition of deacetoxycephalosporin C synthase (DAOCS) and isopenicillin N synthase (IPNS) structures revealed that R74, R160, R266 and N304 are strategically located in the catalytic cavity of Streptomyces clavuligerus DAOCS (scDAOCS) and are crucial for orchestrating different substrates. Substitutions at these sites to a hydrophobic leucine residue were expected to stabilize the hydrophobic substrate bound state. Substantial improvements in the biotransformation of penicillin G, ampicillin and amoxicillin to their respective cephalosporin moieties were observed using the N304L mutant scDAOCS. Thus, our results have demonstrated the enhancement of scDAOCS activity via critical computational analysis and site-directed mutagenesis of endogenous ligands. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11554757     DOI: 10.1006/bbrc.2001.5552

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Engineering Streptomyces clavuligerus deacetoxycephalosporin C synthase for optimal ring expansion activity toward penicillin G.

Authors:  Chia-Li Wei; Yunn-Bor Yang; Wen-Ching Wang; Wen-Chi Liu; Jyh-Shing Hsu; Ying-Chieh Tsai
Journal:  Appl Environ Microbiol       Date:  2003-04       Impact factor: 4.792

2.  A complete library of amino acid alterations at N304 in Streptomyces clavuligerus deacetoxycephalosporin C synthase elucidates the basis for enhanced penicillin analogue conversion.

Authors:  Hong Soon Chin; Kian Sim Goo; T S Sim
Journal:  Appl Environ Microbiol       Date:  2004-01       Impact factor: 4.792

3.  Relevant double mutations in bioengineered Streptomyces clavuligerus deacetoxycephalosporin C synthase result in higher binding specificities which improve penicillin bioconversion.

Authors:  Kian Sim Goo; Chun Song Chua; Tiow-Suan Sim
Journal:  Appl Environ Microbiol       Date:  2007-12-14       Impact factor: 4.792

4.  Modified Deacetylcephalosporin C Synthase for the Biotransformation of Semisynthetic Cephalosporins.

Authors:  Nataraj Balakrishnan; Sadhasivam Ganesan; Padma Rajasekaran; Lingeshwaran Rajendran; Sivaprasad Teddu; Micheal Durairaaj
Journal:  Appl Environ Microbiol       Date:  2016-06-13       Impact factor: 4.792

5.  Directed evolution of Streptomyces clavuligerus deacetoxycephalosporin C synthase for enhancement of penicillin G expansion.

Authors:  Chia-Li Wei; Yunn-Bor Yang; Chan-Hui Deng; Wen-Chi Liu; Jyh-Shing Hsu; Yu-Ching Lin; Shwu-Huey Liaw; Ying-Chieh Tsai
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

Review 6.  Directed evolution and rational approaches to improving Streptomyces clavuligerus deacetoxycephalosporin C synthase for cephalosporin production.

Authors:  Kian-Sim Goo; Chun-Song Chua; Tiow-Suan Sim
Journal:  J Ind Microbiol Biotechnol       Date:  2009-03-07       Impact factor: 3.346

Review 7.  Engineering deacetoxycephalosporin C synthase as a catalyst for the bioconversion of penicillins.

Authors:  Keqiang Fan; Baixue Lin; Yong Tao; Keqian Yang
Journal:  J Ind Microbiol Biotechnol       Date:  2016-11-08       Impact factor: 3.346

8.  Family shuffling of expandase genes to enhance substrate specificity for penicillin G.

Authors:  Jyh-Shing Hsu; Yunn-Bor Yang; Chan-Hui Deng; Chia-Li Wei; Shwu-Huey Liaw; Ying-Chieh Tsai
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

9.  Deacetoxycephalosporin C synthase (expandase): Research progress and application potential.

Authors:  Xiaofan Niu; Jian Zhang; Xianli Xue; Depei Wang; Lin Wang; Qiang Gao
Journal:  Synth Syst Biotechnol       Date:  2021-11-23

Review 10.  Streptomycetes as platform for biotechnological production processes of drugs.

Authors:  Simona Barbuto Ferraiuolo; Marcella Cammarota; Chiara Schiraldi; Odile Francesca Restaino
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-04       Impact factor: 4.813

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.